Amarin Corp Plcuk (AMRN) Short term Debt (2013 - 2020)
Amarin Corp Plcuk (AMRN) reported Short term Debt of $9.5 million for Q3 2020, down 81.5% year-over-year from $51.2 million in Q4 2019, and down 57.84% quarter-over-quarter from $22.5 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Short term Debt (2013 - 2020) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 8 years of Short term Debt data on file, last reported at $9.5 million in Q3 2020.
- Short term Debt for Q3 2020 came in at $9.5 million, down 81.5% year-over-year; the trailing twelve-month figure through Sep 2020 was $9.5 million (down 81.5% YoY), and the FY2019 annual result was $50.1 million, up 46.41% from the prior year.
- Short term Debt retreated to $9.5 million in Q3 2020 per AMRN's latest filing, from $22.5 million in the prior quarter.
- Over five years, Short term Debt peaked at $51.2 million in Q3 2019 and troughed at $219000.0 in Q3 2017.
- A 5-year average of $22.4 million and a median of $22.3 million in 2017 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2017 and 2019: Short term Debt slumped 98.52% in 2017, then soared 23263.47% in 2019.
- A 5-year view of Short term Debt shows it stood at $15.4 million in 2016, then surged by 45.58% to $22.3 million in 2017, then surged by 53.21% to $34.2 million in 2018, then soared by 46.41% to $50.1 million in 2019, then plunged by 81.12% to $9.5 million in 2020.
- Business Quant data shows AMRN's Short term Debt at $9.5 million in Q3 2020, $22.5 million in Q2 2020, and $37.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 9.47 Mn |
| Jun 30, 2020 | 22.46 Mn |
| Mar 31, 2020 | 36.98 Mn |
| Dec 31, 2019 | 50.13 Mn |
| Sep 30, 2019 | 51.17 Mn |
| Jun 30, 2019 | 45.41 Mn |
| Mar 31, 2019 | 38.96 Mn |
| Dec 31, 2018 | 34.24 Mn |
| Sep 30, 2018 | 219,000.00 |
| Jun 30, 2018 | 481,000.00 |
| Mar 31, 2018 | 24.37 Mn |
| Dec 31, 2017 | 22.35 Mn |
| Sep 30, 2017 | 219,000.00 |
| Jun 30, 2017 | 455,000.00 |
| Mar 31, 2017 | 17.00 Mn |
| Dec 31, 2016 | 15.35 Mn |
| Sep 30, 2016 | 13.47 Mn |
| Jun 30, 2016 | 30.82 Mn |
| Mar 31, 2016 | 12.73 Mn |
| Dec 31, 2015 | 12.48 Mn |